Lydia Meziani

Years Active: 2021-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Lydia Meziani, Marine Gerbé de Thoré, Céline Clémenson, Winchygn Liu, Pierre-Antoine Laurent, Michele Mondini, Marie-Catherine Vozenin, Eric Deutsch
Optimal dosing regimen of CD73 blockade improves tumor response to radiotherapy through iCOS downregulation. Journal for immunotherapy of cancer 11 (6) (2023)
Pauline Hamon, Marine Gerbé De Thoré, Marion Classe, Nicolas Signolle, Winchygn Liu, Olivia Bawa, Lydia Meziani, Céline Clémenson, Fabien Milliat, Eric Deutsch, Michele Mondini
TGFβ receptor inhibition unleashes interferon-β production by tumor-associated macrophages and enhances radiotherapy efficacy. Journal for immunotherapy of cancer 10 (3) (2022)
Lydia Meziani, Marine Gerbé de Thoré, Pauline Hamon, Sophie Bockel, Ruy A Louzada, Céline Clemenson, Raphaël Corre, Winchygn Liu, Corinne Dupuy, Michele Mondini, Eric Deutsch
Dual oxidase 1 limits the IFNγ-associated antitumor effect of macrophages. Journal for immunotherapy of cancer 8 (1) (2021)

Lydia Meziani.css-eqlu8i{font-size:small;padding-left:4px;}